Contemporaneous Trachyandesitic and Calc-alkaline Volcanism of the Huerto Andesite, San Juan Volcanic Field, Colorado, USA

Locally, voluminous andesitic volcanism both preceded and followed large eruptions of silicic ash-flow tuff from many calderas in the San Juan volcanic field. The most voluminous post-collapse lava suite of the central San Juan caldera cluster is the 28 Ma Huerto Andesite, a diverse assemblage erupted from at least 5-6 volcanic centres that were active around the southern margins of the La Garita caldera shortly after eruption of the Fish Canyon Tuff. These andesitic centres are inferred, in part, to represent eruptions of magma that ponded and differentiated within the crust below the La Garita caldera, thereby providing the thermal energy necessary for rejuvenation and remobilization of the Fish Canyon magma body. The multiple Huerto eruptive centres produced two magmatic series that differ in phenocryst mineralogy (hydrous vs anhydrous assemblages), whole-rock major and trace element chemistry and isotopic compositions. Hornblende-bearing lavas from three volcanic centres located close to the southeastern margin of the La Garita caldera (Eagle Mountain-Fourmile Creek, West Fork of the San Juan River, Table Mountain) define a high-K calc-alkaline series (57-65 wt % SiO2) that is oxidized, hydrous and sulphur rich. Trachyandesitic lavas from widely separated centres at Baldy Mountain-Red Lake (western margin), Sugarloaf Mountain (southern margin) and Ribbon Mesa (20 km east of the La Garita caldera) are mutually indistinguishable (55-61 wt % SiO2); they are characterized by higher and more variable concentrations of alkalis and many incompatible trace elements (e.g. Zr, Nb, heavy rare earth elements), and they contain anhydrous phenocryst assemblages (including olivine). These mildly alkaline magmas were less water rich and oxidized than the hornblende-bearing calc-alkaline suite. The same distinctions characterize the voluminous precaldera andesitic lavas of the Conejos Formation, indicating that these contrasting suites are long-term manifestations of San Juan volcanism. The favoured model for their origin involves contrasting ascent paths and differentiation histories through crustal columns with different thermal and density gradients. Magmas ascending into the main focus of the La Garita caldera were impeded, and they evolved at greater depths, retaining more of their primary volatile load. This model is supported by systematic differences in isotopic compositions suggestive of crust-magma interactions with contrasting lithologie

The Review of Economic Performance and Social Progress 2002: Towards a Social Understanding of Productivity

In this chapter, Peter Dungan investigates the sensitivity of Canadian government fiscal balances to alternative long-run productivity growth rates using elements of the FOCUS macroeconometric model to conduct simulations on a 'base-case' projection of the Canadian economy, and of its fiscal detail, through the year 2030. The simulation strategy employed here in part parallels the technique used by the Department of Finance in recent budgets and fiscal statements to estimate the implicit size of the 'fiscal dividend'. A total of five alternative growth paths and sensitivity tests are presented. As Dungan points out changes in productivity growth rates can occur for a variety of reasons and can have many different possible effects on the economy. Therefore, these types of simulation exercises inevitably require a number of simplifying assumptions which must be taken into account in interpreting the results.Productivity, Fiscal Balances, Fiscal Policy, Revenues, Government Revenues, Taxes, Tax, Taxation, Social Programs, Social Spending, Social Policy, Expenditures, Government Expenditures, Government, Econometric Forecasting, Forecasting, FOCUS, Macroeconometric, Macro-econometric, Econometric Modeling

Phytoene Accumulation in the Novel Microalga Chlorococcum sp. Using the Pigment Synthesis Inhibitor Fluridone

Carotenoids are lipophilic pigments found in plants and algae, as well as some bacteria, archaea, and fungi that serve two functions—(1) as light harvesting molecules—primary carotenoids, and (2) as antioxidants, acting against reactive oxygen species–secondary carotenoids. Because of their strong antioxidant properties, they are also valuable for the development of anti-aging and photo-protective cosmetic applications. Of particular interest is the carotenoid phytoene, for its colorless and UV absorption characteristics. In this study, we targeted a reduction of phytoene desaturase (PDS) activity with the pigment-inhibiting herbicide 1-methyl-3-phenyl-5-[3- (trifluoromethyl)phenyl]pyridin-4-one (fluridone), which leads to the over-accumulation of phytoene in the recently characterized microalgal strain Chlorococcum sp. (UTEX B 3056). After post-incubation with fluridone, phytoene levels were measured at ~33 ug/mg cell tissue, as opposed to non-detectable levels in control cultures. Hence, the novel microalga Chlorococcum sp. is a viable candidate for the production of the high-value carotenoid phytoene and subsequent applications in cosmeceuticals, as well as more obvious nutraceutical and pharmaceutical applications

Surface Biology & Geology Pathfinder Data Analysis Pipeline

NASA's future global orbital mission, currently in development as the Surface Biology and Geology (SBG) Designated Observable study, will acquire relatively high resolution solar-reflected spectroscopy and thermal infrared observations. Innovative processes must be utilized for handling the high volume of data anticipated to be collected, which is anticipated to exceed 100 terabytes/day, greater than NASA's total extant airborne hyperspectral data collection. Collecting, processing/re-processing, disseminating, and exploiting this volume of data presents new challenges. To begin addressing them, NASA is drawing upon the expertise developed from its astrophysics programs to address Earth science and applications. Specifically, NASA is adapting the science processing operations technology developed for the Kepler and TESS planet-hunting missions for imaging spectroscopy data processing. This technology development has been the foundation for the remarkable scientific successes of Kepler and TESS. The Kepler/TESS data processing technology provides a scalable architecture for robust, repeatable, and replicable science and application products while enabling the Earth science community to develop, test, and implement new algorithms. Our effort to leverage this existing capability has begun by ingesting data and applying workflows from the EO-1/Hyperion 17-year mission archive that provides globally sampled visible through shortwave infrared spectra that are representative of SBG data types and volumes. This pathfinding data processing system will help define the solutions to processing SBG data volumes and will enable the scientific community to interact with the data and processing pipeline to create new science products

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

The CPP Payroll Tax Hike: Macroeconomic Transition Costs and Alternatives

The FOCUS macroeconomic model is used to estimate the impact of the CPP premium increases introduced in 1997. It is found that these will have relatively severe macroeconomic consequences in the short to medium term, although they will put the plan on a sound fiscal footing. Additional simulations explore how the macroeconomic damage of the CPP rate hikes could be mitigated. One method would be to "privatize" the CPP such that employers would no longer be taxed. A second alternative is to cap the CPP premium at the planned 1999 rate of 7 percent in 2000 and beyond, and collect the funds required to finance the unfunded CPP liabilities through the income tax. A final simulation indicates that if the current plan for CPP rate hikes is not amended it will be imperative that Employment Insurance rates be massively reduced over the next few years.